International — Revenue
Eli Lilly International — Revenue increased by 2.6% to $19.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 55.5%, from $12.73B to $19.80B. Over 4 years (FY 2021 to FY 2025), International — Revenue shows an upward trend with a 23.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests successful global expansion and strong international demand for the company's drug portfolio, while a decrease may indicate competitive pressure, pricing challenges, or unfavorable currency headwinds in foreign markets.
Detailed definition
This metric represents the total net sales generated by the company from operations outside of its primary domestic mark...
Peer comparison
Most large-cap pharmaceutical companies report geographic revenue splits, allowing for comparison of global footprint and reliance on non-domestic markets versus peers like Pfizer or Merck.
lly_segment_international_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.74B | $6.77B | $8.00B | $7.81B | $6.49B | $6.94B | $7.30B | $6.96B | $8.31B | $9.50B | $9.35B | $8.77B | $11.30B | $11.44B | $13.53B | $12.73B | $15.56B | $17.60B | $19.29B | $19.80B |
| QoQ Change | — | +0.5% | +18.1% | -2.4% | -16.9% | +7.0% | +5.2% | -4.7% | +19.4% | +14.3% | -1.5% | -6.3% | +28.9% | +1.2% | +18.3% | -5.9% | +22.2% | +13.1% | +9.6% | +2.6% |
| YoY Change | — | — | — | — | -3.7% | +2.5% | -8.7% | -10.9% | +28.1% | +36.8% | +28.1% | +26.0% | +36.0% | +20.4% | +44.7% | +45.2% | +37.6% | +53.9% | +42.6% | +55.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's international — revenue?
- Eli Lilly (LLY) reported international — revenue of $19.80B in Q1 2026.
- How has Eli Lilly's international — revenue changed year-over-year?
- Eli Lilly's international — revenue increased by 55.5% year-over-year, from $12.73B to $19.80B.
- What is the long-term trend for Eli Lilly's international — revenue?
- Over 4 years (2021 to 2025), Eli Lilly's international — revenue has grown at a 23.2% compound annual growth rate (CAGR), from $28.32B to $65.18B.
- What does international — revenue mean?
- The total revenue earned by the company from sales in countries outside of its home market.